Search

Your search keyword '"Kong, V."' showing total 254 results

Search Constraints

Start Over You searched for: Author "Kong, V." Remove constraint Author: "Kong, V." Topic business Remove constraint Topic: business
254 results on '"Kong, V."'

Search Results

1. Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis

2. Expression Analysis of GD2 by Immunohistochemistry in Invasive Breast Carcinoma: Clinical and Pathologic Correlation

3. Team dynamics in emergency surgery teams: results from a first international survey

4. Trauma quality indicators: internationally approved core factors for trauma management quality evaluation

5. B7H3-Directed Intraperitoneal Radioimmunotherapy With Radioiodinated Omburtamab for Desmoplastic Small Round Cell Tumor and Other Peritoneal Tumors: Results of a Phase I Study

6. Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells

7. IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab—pharmacokinetic modeling to optimize therapeutic index

8. Targets and Antibody Formats for Immunotherapy of Neuroblastoma

9. Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies

10. KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up

11. Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor

12. Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy

13. Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors

14. Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes

15. Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release

16. Potent antitumor effect of T cells armed with anti‐GD2 bispecific antibody

17. Surgical site infection after gastrointestinal surgery in children: An international, multicentre, prospective cohort study

18. Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression

19. GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma

21. Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining

22. A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy

23. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma

24. Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer

25. Immunotherapy Targeting ST2/IL-33 Signaling in Myeloid Leukemia Stem Cells

26. Intra-operative gallbladder scoring predicts conversion of laparoscopic to open cholecystectomy : a WSES prospective collaborative study

27. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma

28. MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy

29. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer

30. Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies

31. Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma

32. THER-24. TARGETED RADIOIMMUNOTHERAPY FOR EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES

33. Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma

34. Reduced-dose Radiation Therapy to the Primary Site is Effective for High-risk Neuroblastoma: Results from a Prospective Trial

35. Phase 1 dose-escalation trial using convection-enhanced delivery of radiolabeled monoclonal antibody for diffuse intrinsic pontine glioma following external radiation therapy

36. T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia

37. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

38. Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma

39. A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma

40. Abstract LB-092: Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma

41. Development of a tetravalent anti-GPA33/anti-CD3 bispecific antibody for colorectal cancers

42. EPEN-04. RECURRENT EPENDYMOMA: ROLE OF INTRAVENTRICULAR TARGETED RADIOIMMUNOTHERAPY

43. Laparoscopy in management of appendicitis in high, middle and low income countries: A multicenter, prospective, cohort study

44. Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

45. Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity 86Y- or 177Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates

46. Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy

47. Desmoplastic small round cell tumor 20 years after its discovery

48. Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology

49. Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy

50. Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival

Catalog

Books, media, physical & digital resources